Copertina

Real‐World Weight‐Loss Outcomes in Weight‐Reduced Patients Treated With Tirzepatide

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sarah R. Barenbaum, Ariel Gonzalez, Zoe Verzani, Alice S. Zhao, Alpana P. Shukla
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Obesity
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
di: Sharath Kommu, et al.
Pubblicazione: (2025)

Real‐World Weight Loss Is Associated With a Reduction in Cancer Risk
di: Kenda Alkwatli, et al.
Pubblicazione: (2026)

Interpreting Lean Mass Changes During Tirzepatide‐Induced Weight Loss: Beyond Quantitative Metrics
di: Tuba Uyanık
Pubblicazione: (2026)

Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN
di: Deborah B. Horn, et al.
Pubblicazione: (2025)

Comment on ‘Semaglutide and Tirzepatide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World ( STEER )’
di: Chih‐Yuan Wang
Pubblicazione: (2026)

Real‐World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non‐Diabetic Adults
di: Mai Katsura, et al.
Pubblicazione: (2026)

Early Weight Loss and Other Factors Associated With Clinically Significant Weight Loss in Two Commercial Weight Loss Programmes
di: Christopher D. Coleman, et al.
Pubblicazione: (2025)

The POWER of Sleep in Promoting Weight Loss Among Breast Cancer Survivors
di: Sarah Schmitz, et al.
Pubblicazione: (2026)

Dapagliflozin‐Associated Reduction in Liver Fat Is Independent of Weight Loss in Patients With Type 2 Diabetes
di: Anna V. Naumova, et al.
Pubblicazione: (2026)

Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice
di: Zachary J. Fennel, et al.
Pubblicazione: (2025)

Dietary Macronutrient Composition and Protein Concentration for Weight Loss Maintenance
di: Hanyue Zhang, et al.
Pubblicazione: (2025)

Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity
di: Kara D. Denstel, et al.
Pubblicazione: (2026)

Trends in Weight Loss Attempts and Strategies Among US Adolescents With Overweight or Obesity
di: Ligang Liu, et al.
Pubblicazione: (2026)

Long‐Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change
di: Jennifer M. Clark, et al.
Pubblicazione: (2025)

Weight Loss‐Associated Remodeling of Adipose Tissue Immunometabolism
di: Paulo José Basso, et al.
Pubblicazione: (2025)

Association Between Wake‐Time Movement Behaviors and Weight Loss Maintenance
di: Chelsea L. Kracht, et al.
Pubblicazione: (2025)

Correction to “Long‐Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change”
Pubblicazione: (2025)

GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study
di: Dina H. Griauzde, et al.
Pubblicazione: (2026)

Effect of Tirzepatide on Health‐Related Quality of Life in Japanese Patients With Obesity Disease: Patient‐Reported Outcomes From the SURMOUNT ‐J Study
di: Hiroaki Masuzaki, et al.
Pubblicazione: (2026)

Outcomes of Endoscopic Sleeve Gastroplasty ( ESG ) at a Single Institution: The First Report on Weight Loss and Complication Rates in Japan
di: Kodai Takahashi
Pubblicazione: (2025)

From Weight Loss to Multimorbidity Prevention: Framing the Anticipated Contributions of SURMOUNT ‐ MMO
di: Naveed Sattar
Pubblicazione: (2025)

A Qualitative Analysis of Patient Experiences Using Semaglutide 2.4 mg for Weight Loss
di: Eion Plenn, et al.
Pubblicazione: (2025)

Longitudinal Effects of a Digital Weight Management Program on Weight Loss: A Randomized Controlled Trial
di: Meaghan McCallum, et al.
Pubblicazione: (2026)

The Role of Insulin Sensitivity in Lean Mass Changes During Weight Loss With or Without Exercise
di: Ciera L. Bartholomew, et al.
Pubblicazione: (2025)

CRISPLD2 : A Weight Loss‐Induced Adipokine With Antifibrotic Capabilities in Adipose Tissue
di: David Mendoza, et al.
Pubblicazione: (2025)

Weight Loss Before Basic Combat Training and Musculoskeletal Injuries Among U.S. Army Trainees: The ARMI Study
di: Vy T. Nguyen, et al.
Pubblicazione: (2025)

Differences in Weight Loss Postsleeve Gastrectomy Among Patients With Various Types of Obesity Based on Waist‐To‐Hip Ratio Classification
di: Pengxiang Luan, et al.
Pubblicazione: (2025)

Weight Loss With GLP ‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis
di: Michael Lim, et al.
Pubblicazione: (2026)

Parental Communication With Children Around Obesity Management Medications, Weight Loss, and Health Behavior Change
di: Keeley J. Pratt, et al.
Pubblicazione: (2026)

Impact of Genetic Predisposition to Obesity on Long‐Term Maintenance of Modest Weight Loss in Postmenopausal Women
di: Harold H. Lee, et al.
Pubblicazione: (2026)

Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery
di: Amanda Finn, et al.
Pubblicazione: (2025)

Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
di: Hamlet Gasoyan, et al.
Pubblicazione: (2025)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
di: Giorgia Rutigliani, et al.
Pubblicazione: (2026)

Impact of Anti‐obesity Medication Initiation and Duration on Weight Loss
di: M. Rami Bailony, et al.
Pubblicazione: (2025)

Real‐World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido‐ TZP Study
di: Fumika Maruyama, et al.
Pubblicazione: (2026)

Six‐Month Real‐World Effectiveness, Persistence and Safety of Low‐to‐Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study
di: Nikolaos Angelopoulos, et al.
Pubblicazione: (2026)

Patterns of Dietary Supplement Use for Weight Loss Among U.S. Adults With Obesity: NHANES 2007–2020
di: Ligang Liu, et al.
Pubblicazione: (2026)

Impact of Weight Management Advice From Healthcare Providers on Weight Loss in Individuals With Type 2 Diabetes and Overweight or Obesity
di: Xiaoyue Zhang, et al.
Pubblicazione: (2026)

Cardiometabolic Gains Unrelated to Weight Loss–Adjusted Body Fat or Distribution Changes in Adults With and Without Diabetes
di: Jose E. Galgani, et al.
Pubblicazione: (2026)

Weight Loss With SGLT2 Inhibitors, Semaglutide, and Transcranial Magnetic Stimulation in Type 2 Diabetes and Obesity
di: Anna Ferrulli, et al.
Pubblicazione: (2025)